Vimarsana
Biggest News Aggregation in the World

Eman Rashed News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eman Rashed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eman Rashed Today - Breaking & Trending Today

5 cardiologists to know - Vimarsana News

5 cardiologists to know

Get to know five top cardiologists making waves in the field, including new medical directors, practice reopenings, and innovative procedures.

Newark Beth Israel adds to heart failure team - Vimarsana News

Newark Beth Israel adds to heart failure team

Learn about the newest addition to Newark Beth Israel Medical Center's advanced heart failure team, Dr. Eman Rashed, who specializes in cardio-obstetrics.

Lower Dose of Edoxaban Supported in ENGAGE-AF-TIMI 48 Analysis - Vimarsana News

Lower Dose of Edoxaban Supported in ENGAGE-AF-TIMI 48 Analysis

March 02, 2021 The lower dose of edoxaban (Savaysa; Daiichi-Sankyo) evaluated in ENGAGE AF-TIMI 48 provides a net clinical benefit, according to a new analysis of the trial, suggesting it may be useful for some patients with atrial fibrillation (AF). The trial evaluated two doses of the direct oral anticoagulant (DOAC) versus warfarin—60 and 30 mg once daily; both could be cut in half in patients meeting certain criteria. The rate of a net clinical outcome incorporating stroke/systemic embolism, major bleeding, or death was significantly lower in patients who received the lower- versus high...

Source: tctmd.com